On July 6, President Xi Jinping arrived in Hamburg, Germany, by special flight to attend the 12th summit of G20 leaders. He met with a number of heads of state.

             - www.people.com.cn, July 7

Since President Xi Jinping took office, he has visited all over the world and has been received at the highest level in all countries he has visited. The reasons for this are, firstly, President Xi's outstanding leadership and charisma, and secondly, the fact that in recent years China has successfully established an international image of being responsible in international affairs, which is based on the strong rise of China's economic and military strength.

Putting aside the military aspect, the "China speed" achieved in the economic development tide over the past 40 years since the reform and opening up is a Chinese road that is admired by other countries but cannot work the same way for them. On this unique road to rejuvenation, China has made harder efforts than European and American countries. The wide application of traditional virtues such as "patriotism, ambition, self-improvement, integrity, courage, studiousness and benevolence" in the new era has inspired the great creativity of Chinese people and promoted the rapid development and rise of China's economy.

Economic Daily and www.people.com.cn pointed out in the article titled Revitalization of Real Economy Cannot be Done Without Contributions from Private Enterprises, "The real economy is always the foundation of China's development… Revitalization of the real economy requires the development of private economy… Private economy has become an important driver of economic growth". In the tide of vigorous development of China's private economy, private enterprises shouldering the heavy responsibility of national rejuvenation have made unimaginable great efforts behind the prosperity.

As a private pharmaceutical enterprise, Hansoh Pharma, since its establishment, has been pursuing the mission to "create excellence in pharmaceuticals and enhance innovation in China"; it has long been committed to providing Chinese people with excellent quality drugs and providing the society with an excellent career development platform through innovative research and design of drugs, and has made breakthrough development in many fields.

Scientific and technological innovation

Over the years, Hansoh Pharma's drug research and development has successfully realized the strategic shift from "generic-innovative combination" to innovation basis, with a number of national Class 1.1 new drugs now at various stages of research and development. In 2014, the launch of Mailingda, a national Class 1.1 innovative drug, was a key symbol of Hansoh's R&D transformation and upgrading. Of the 40+ varieties that have been marketed, two drugs have won the second prize of National Science and Technology Progress Award for R&D, and one drug has won China Patent Gold Award. Hansoh Pharma has successively undertaken more than 40 national-level projects such as 863 Program, National Major Scientific and Technological Special Project for "Significant New Drugs Development", and Chinatorch Program, making positive contributions to the scientific and technological development of the national pharmaceutical field.

In recent years, in order to adapt to the development trend of the world pharmaceutical industry and the national strategic needs, the company has integrated high-quality scientific research resources globally, conducted global multi-center clinical studies on a number of innovative drugs and generic drugs at the same time, and carried out research on the most cutting-edge pharmaceutical technology.

Intelligent manufacturing

In order to meet the expanding market demand, Hansoh Pharma has invested in the establishment of a number of high-standard production bases covering important nodes of the industrial chain such as preparations, APIs and intermediates. The Modern Preparation Industrial Park, which is located in the National Economic and Technological Development Zone and meets the EU standards, is a demonstration project of technological transformation in Jiangsu Province and a major engineering project under the supervision of the local government. At present, it has been fully put into production, enabling automatic material collection, assembly line production and data collection, completely eliminating man-induced differences, ensuring drugs' conformity to international advanced quality control level, and providing core competitiveness for the acceleration of Hansoh Pharma's go-global process. High-efficiency production capacity and market development capacity have also made great contributions to the development of the local economy - Hansoh Pharma is one of the top 100 taxpayers in Jiangsu Province and the top 10 taxpayers in Lianyungang City.

Talent development

In 1988, Mr. Deng Xiaoping put forward the conclusion that "science and technology are the primary productive forces" at the National Science Conference.

During his visit to Tsinghua University, President Xi Jinping noted that "we will uphold the concept that science and technology are the primary productive forces and talents are the primary resources, incorporate diverse elements, learn from internationally leading practices, train more and higher quality talents, and also provide a broader space for all kinds of talents to play their roles and display their talents".

The two national leaders have both made profound judgments and requirements on science & technology and talents, and it is on the basis of this theory that Hansoh has persisted in the development of pharmaceutical science and technology innovation, especially the engagement and internal training of scientific and technological talents, for years.

Over the years, Hansoh Pharma has always adhered to the "people-oriented" talent strategy; through the "administrative, technical" dual-channel development and the three programs of paratroopers, shepherds and accumulators, it has built a talent development system of "attracting people through career, uniting people through culture, growing people through learning, and motivating people through mechanism", providing a broad development platform for outstanding talents in society.

In this way, the excellent corporate culture has been well inherited and carried forward, and all employees have established a strong sense of responsibility, progress and gratitude. In the process of Hansoh Pharma 's many leaps and bounds, it is also these elites from all over the country and even the world who have formed one core team after another to provide continuous impetus for the development of the enterprise.

In such a cultural context, everyone has a good platform and mechanism to achieve self-worth, and everyone's potential is harnessed to the fullest, forming a good atmosphere of positive, active and hard learning. As a result, employee have broadened horizons and improved knowledge and skills, thereby securing and maintaining transcendent competitiveness under the fierce market competition and rapidly changing industry development situation.

Mr. Lu Xun was quoted saying in his Demi-Concession Studio Essays that, "What is unique for a nation is also precious for the world."

Great powers bear great responsibilities; leading enterprises lead in CSR practices. Hansoh Pharma 's development over the past 22 years is indeed a microcosm of Chinese pharmaceutical enterprises' responsible and credible efforts in the booming tide. Only when Chinese enterprises bravely take up the heavy responsibility of national rejuvenation, can the tide of great economic development in China become stronger, forming an irreversible momentum and promoting the early realization of the Chinese dream.